These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7531979)

  • 1. Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificity.
    Bach JF; Chatenoud L
    Chem Immunol; 1995; 60():32-47. PubMed ID: 7531979
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
    Eldor R; Cohen IR; Raz I
    Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin--a primary autoantigen in type 1 diabetes?
    Wong FS
    Trends Mol Med; 2005 Oct; 11(10):445-8. PubMed ID: 16150642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.
    Wong FS; Karttunen J; Dumont C; Wen L; Visintin I; Pilip IM; Shastri N; Pamer EG; Janeway CA
    Nat Med; 1999 Sep; 5(9):1026-31. PubMed ID: 10470079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Tisch R; Yang XD; Singer SM; Liblau RS; Fugger L; McDevitt HO
    Nature; 1993 Nov; 366(6450):72-5. PubMed ID: 8232539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.
    Filippi C; Bresson D; von Herrath M
    Int Rev Immunol; 2005; 24(5-6):341-60. PubMed ID: 16318986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus.
    Roep BO; Hiemstra HS; Schloot NC; De Vries RR; Chaudhuri A; Behan PO; Drijfhout JW
    Ann N Y Acad Sci; 2002 Apr; 958():163-5. PubMed ID: 12021098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
    Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
    J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes.
    Weenink SM; Lo J; Stephenson CR; McKinney PA; Ananieva-Jordanova R; Rees Smith B; Furmaniak J; Tremble JM; Bodansky HJ; Christie MR
    J Autoimmun; 2009 Sep; 33(2):147-54. PubMed ID: 19447008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive T cells in human type 1 diabetes.
    Tree TI; Peakman M
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera.
    Choi SE; Kim KS; Kim KH; Choi UY; Kim HM; Yoon JW; Kang Y
    J Autoimmun; 2000 Nov; 15(3):347-57. PubMed ID: 11040075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
    Shekhar C
    Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
    [No Abstract]   [Full Text] [Related]  

  • 17. Spotting a killer's target in autoimmune diabetes.
    Benoist C; Mathis D
    Nat Med; 1999 Sep; 5(9):992-3. PubMed ID: 10470072
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop.
    Nagata M; Kotani R; Moriyama H; Yokono K; Roep BO; Peakman M
    Ann N Y Acad Sci; 2004 Dec; 1037():10-5. PubMed ID: 15699487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects.
    Semana G; Gausling R; Jackson RA; Hafler DA
    J Autoimmun; 1999 Jun; 12(4):259-67. PubMed ID: 10330297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.